Funder: National Institutes of Health
Due Dates (Anticipated): July 2026 (Full application deadline, projected)
Funding Amounts: Expected 10 awards; typical NIH U01 cooperative agreement—award size and duration vary, see program for details.
Summary: Supports multidisciplinary research on early detection of pancreatic ductal adenocarcinoma (PDAC) and characterization of precursor lesions through biomarker and imaging development, validation, and collaborative consortium activities.
Key Information: This is a forecasted opportunity; all deadlines are projected and subject to change.